mRNA vaccines scope expands beyond COVID-19

While SARS-CoV-2 vaccines have been capturing the limelight, there has also been progress in other vaccines relevant to travel medicine

The remarkable and rapid progress on development of SARS-CoV-2 vaccines has understandably dominated discussions of vaccine development over the past two years.

Even as the WHO declared COVID-19 a pandemic on 11 March 2020, there were more than 35 biotechnology and academic groups around the world working on vaccine candidates.